Table 1.
Parameter | Adenine Administration Period | |||
---|---|---|---|---|
0 wk | 2 wk | 4 wk | 5 wk | |
Food intake (g/d) | ||||
Group LPa | 18.7±2.4 | 27.0±3.0 | 29.0±7.9 | 33.0±7.6 |
Group Adeb | 19.7±1.4 | 18.3±3.9 | 11.7±3.5 | 11.5±1.0 |
Group Gly | 21.1±2.5 | 15.4±7.3 | 15.1±8.9 | 10.0±5.5 |
Group Lys | 22.3±3.4 | 15.3±7.2 | 17.0±9.5 | 14.8±8.1 |
Water intake (ml/d) | ||||
Group LPc | 33.0±3.3 | 21.7±1.5 | 18.3±3.9 | 18.3±4.5 |
Group Adeb | 36.6±6.3 | 52.9±4.9 | 41.4±6.4 | 38.5±14.4 |
Group Gly | 35.7±5.6 | 46.6±6.7 | 44.6±6.7 | 36.3±4.8 |
Group Lys | 35.3±3.7 | 57.0±5.6 | 48.7±4.8 | 44.4±15.2 |
Body weight (g) | ||||
Group LPa | 396.0±8.4 | 400.0±9.7 | 389.0±18.9 | 388.3±16.7 |
Group Adeb | 400.3±6.9 | 332.9±10.3 | 289.7±18.5 | 255.5±19.8 |
Group Gly | 400.0±14.8 | 324.3±16.1 | 283.4±11.9 | 240.3±10.5 |
Group Lys | 400.7±5.8 | 315.0±11.8 | 279.7±14.2 | 242.8±18.0 |
Physical parameters are summarized. All results are presented as means±SD. Statistical significance was evaluated by multivariate ANOVA (n=4–7 in each group).
P<0.001.
Reference group.
P<0.05.